IPO registrations (S-1, F-1) · Registrants

ACCENTIA BIOPHARMACEUTICALS INC

SEC CIK
1310094 · filings on EDGAR ↗
Registration
Form S-1, first filed 2005-02-11, last 2012-06-27; 6 initial registrations, 14 amendments
Outcome
Final prospectus filed 2005-10-28; declared effective 2006-06-22; withdrawal requested 2013-02-22
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
FL
Business address
324 SOUTH HYDE PARK AVE, SUITE 350, Tampa, FL 33606
EDGAR entity type
operating
Insiders and CEO pay
ACCENTIA BIOPHARMACEUTICALS INC on the corporate pages

Offering terms

Final price
$8.00 per share (424B4 filed 2005-10-28, an initial public offering)
Shares sold
2,400,000
Gross proceeds
$19,200,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol ABPI
Lead underwriters
Jefferies; Stifel
Syndicate
Ferris, Baker Watts; GunnAllen Financial, Inc

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 31

FiledFormWhat it isName as filedEDGAR
2005-02-11S-1S-1 (registration)ACCENTIA BIOPHARMACEUTICALS INC0001193125-05-027148 ↗
2005-04-06S-1/AS-1/A (amendment)ACCENTIA BIOPHARMACEUTICALS INC0001193125-05-071324 ↗
2005-05-16S-1/AS-1/A (amendment)ACCENTIA BIOPHARMACEUTICALS INC0001193125-05-108508 ↗
2005-06-13S-1/AS-1/A (amendment)ACCENTIA BIOPHARMACEUTICALS INC0001193125-05-123911 ↗
2005-06-27S-1/AS-1/A (amendment)ACCENTIA BIOPHARMACEUTICALS INC0001193125-05-131775 ↗
2005-06-30S-1/AS-1/A (amendment)ACCENTIA BIOPHARMACEUTICALS INC0001193125-05-135655 ↗
2005-07-11S-1/AS-1/A (amendment)ACCENTIA BIOPHARMACEUTICALS INC0001193125-05-139820 ↗
2005-09-02S-1/AS-1/A (amendment)ACCENTIA BIOPHARMACEUTICALS INC0001193125-05-179905 ↗
2005-10-03S-1/AS-1/A (amendment)ACCENTIA BIOPHARMACEUTICALS INC0001193125-05-195204 ↗
2005-10-19S-1/AS-1/A (amendment)ACCENTIA BIOPHARMACEUTICALS INC0001193125-05-203800 ↗
2005-10-19S-1/AS-1/A (amendment)ACCENTIA BIOPHARMACEUTICALS INC0001193125-05-203896 ↗
2005-10-27S-1/AS-1/A (amendment)ACCENTIA BIOPHARMACEUTICALS INC0001193125-05-209621 ↗
2005-10-28424B4424B4 (final prospectus)ACCENTIA BIOPHARMACEUTICALS INC0001193125-05-210460 ↗
2006-03-06S-1S-1 (registration)ACCENTIA BIOPHARMACEUTICALS INC0001193125-06-046273 ↗
2006-06-14S-1S-1 (registration)ACCENTIA BIOPHARMACEUTICALS INC0001193125-06-129875 ↗
2006-06-14S-1/AS-1/A (amendment)ACCENTIA BIOPHARMACEUTICALS INC0001193125-06-129884 ↗
2006-06-22EFFECTEFFECT (declared effective)ACCENTIA BIOPHARMACEUTICALS INC9999999995-06-000457 ↗
2006-06-23EFFECTEFFECT (declared effective)ACCENTIA BIOPHARMACEUTICALS INC9999999995-06-000465 ↗
2006-11-17EFFECTEFFECT (declared effective)ACCENTIA BIOPHARMACEUTICALS INC9999999995-06-002394 ↗
2007-07-17EFFECTEFFECT (declared effective)ACCENTIA BIOPHARMACEUTICALS INC9999999995-07-002830 ↗
2008-04-17EFFECTEFFECT (declared effective)ACCENTIA BIOPHARMACEUTICALS INC9999999995-08-001101 ↗
2008-09-24EFFECTEFFECT (declared effective)ACCENTIA BIOPHARMACEUTICALS INC9999999995-08-002930 ↗
2008-09-25EFFECTEFFECT (declared effective)ACCENTIA BIOPHARMACEUTICALS INC9999999995-08-002952 ↗
2011-02-18S-1S-1 (registration)ACCENTIA BIOPHARMACEUTICALS INC0001193125-11-040329 ↗
2012-02-03S-1/AS-1/A (amendment)ACCENTIA BIOPHARMACEUTICALS INC0001193125-12-038795 ↗
2012-03-15S-1S-1 (registration)ACCENTIA BIOPHARMACEUTICALS INC0001193125-12-117583 ↗
2012-03-15S-1/AS-1/A (amendment)ACCENTIA BIOPHARMACEUTICALS INC0001193125-12-117594 ↗
2012-04-02EFFECTEFFECT (declared effective)ACCENTIA BIOPHARMACEUTICALS INC9999999995-12-000916 ↗
2012-06-27S-1S-1 (registration)ACCENTIA BIOPHARMACEUTICALS INC0001193125-12-285645 ↗
2012-07-10EFFECTEFFECT (declared effective)ACCENTIA BIOPHARMACEUTICALS INC9999999995-12-002125 ↗
2013-02-22RWRW (withdrawal request)ACCENTIA BIOPHARMACEUTICALS INC0001214659-13-000988 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2005-10-27S-1/Aregistration statement$2.11--0primary document; price linedocument ↗
2005-10-28424B4final prospectus$8.002,400,000$19,200,000Nasdaq ABPI4primary document; price sentence, shares headline, proceeds table, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
MOAB INVESTMENT LPTenPercentOwner42006–2007
RYLL DENNIS LDirector42006–2007
RYLL TIMOTHY DTenPercentOwner52006–2007
ODONNELL FRANCIS E JRDirector; Director,Officer; Director,Officer,TenPercentOwnerCHAIRMAN & CEO; Chief Executive Officer; Executive Chairman; EXECUTIVE CHAIRMAN212006–2013person page Fuzzy
DUBINSKY JOHN PDirector32006–2008person page Fuzzy
HOPKINS CAPITAL GROUP LLCTenPercentOwner12006
STOGEL STEVEN JDirector32006–2007
KING EDMUNDDirector52006–2012
THOMASON TODD DDirector22006
DUFFEY SAMUEL SOfficerCEO/PRESIDENT/GENERAL COUNSEL; GENERAL COUNSEL; PRESIDENT AND GENERAL COUNSEL62007–2012
Pearce Alan MDirector,Officer; OfficerChief Financial Officer102007–2011
Poole WilliamDirector52007–2012
ARIKIAN STEVENDirector,OfficerChairman/CEO; See General Remarks22008
SCHUBERT DAVID MDirector42008–2012
CHAPMAN CHRISTOPHER CDirector42008–2012
Calder Douglas WOfficerVP Strategic Plan/Cap Markets32011–2012
Hasara Garrison J.OfficerActing Chief Financial Officer32011–2012
Santos CarlosOfficerChief Science Officer; Sr. VP of Prod Dev/Reg Affairs32011–2012

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2012-02-08ACCENTIA BIOPHARMACEUTICALS INCBiotechnology$5,000,000$400,00011

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationACCENTIA BIOPHARMACEUTICALS, INC.FLState business registriesname and state
Plan sponsorACCENTIA BIOPHARMACEUTICALS, INC.FLForm 5500 (employee benefit plans)name and state
Form D issuerACCENTIA BIOPHARMACEUTICALS INCFLForm D private offeringsCIK (EXACT)
IPO registrantBIOVEST INTERNATIONAL INCFLIPO registrations (S-1, F-1)same street address and ZIP code, 324 S HYDE PARK AVE STE 350 33606 (FUZZY: a shared address, not proof of a shared organization)
Patent assigneeAccentia Biopharmaceuticals, Inc.FLPatents (USPTO)name and state
SEC filerACCENTIA BIOPHARMACEUTICALS INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerAccentia Biopharmaceuticals, Inc.FLTrademarks (USPTO)name and state
Person pageFrancis E O'Donnell JrPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)
Person pageJohn P DubinskyPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, FL first:

More with this interest.

In other datasets, the same topic (Health) in FL:

Interests: Pharmaceutical Preparations · Health